Toxicokinetics of kava
- PMID: 21541070
- PMCID: PMC3085297
- DOI: 10.1155/2011/326724
Toxicokinetics of kava
Abstract
Kava is traditionally consumed by South Pacific islanders as a drink and became popular in Western society as a supplement for anxiety and insomnia. Kava extracts are generally well tolerated, but reports of hepatotoxicity necessitated an international reappraisal of its safety. Hepatotoxicity can occur as an acute, severe form or a chronic, mild form. Inflammation appears to be involved in both forms and may result from activation of liver macrophages (Kupffer cells), either directly or via kava metabolites. Pharmacogenomics may influence the severity of this inflammatory response.
Figures
References
-
- Whitton PA, Lau A, Salisbury A, Whitehouse J, Evans CS. Kava lactones and the kava-kava controversy. Phytochemistry. 2003;64(3):673–679. - PubMed
-
- Teschke R, Sarris J, Lebot V. Kava hepatotoxicity solution: a six-point plan for new kava standardization. Phytomedicine. 2011;18(2-3):96–103. - PubMed
-
- Dinh LD, Simmen U, Bueter KB, Bueter B, Lundstrom K, Schaffner W. Interaction of various Piper methysticum cultivars with CNS receptors in vitro. Planta Medica. 2001;67(4):306–311. - PubMed
LinkOut - more resources
Full Text Sources
